Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jelena Vladičić Mašić"'
Autor:
Timur Cerić, Emir Sokolović, Berisa Hasanbegović, Anes Pašić, Zdenka Gojković, Jelena Vladičić Mašić, Nikolina Dukić, Inga Marijanović, Alma Mekić Abazović, Ibrahim Šišić, Dijana Koprić, Mustafa Hammami, Senad Bajramović, Taib Delić, Semir Bešlija
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be reco
Externí odkaz:
https://doaj.org/article/9b0b15bddcc0473c898c2d63ccc6603b
Publikováno v:
Biomedicinska istraživanja, Vol 10, Iss 2, Pp 111-117 (2019)
Introduction. Hematopoiesis is the process of developing blood cells and the formed elements of blood. This dynamic process occurs postnatally in the bone marrow, while the prenatal hematopoiesis is scattered over multiple localizations. It begins
Externí odkaz:
https://doaj.org/article/c21d85dbda9847ddadef1d6877f40a42
Autor:
Semir Bešlija, Zdenka Gojković, Timur Cerić, Alma Mekić Abazović, Inga Marijanović, Semir Vranić, Jasminka Mustedanagić–Mujanović, Faruk Skenderi, Ivanka Rakita, Aleksandar Guzijan, Dijana Koprić, Alen Humačkić, Danijela Trokić, Jasmina Alidžanović, Alma Efendić, Ibrahim Šišić, Harun Drljević, Vanesa Bešlagić, Božana Babić, Azra Pašić, Anela Ramić, Dijana Mikić, Zlatko Guzin, Dragana Karan, Teo Buhovac, Dragana Miletić, Senad Šečić, Azra Đozić Šahmić, Lejla Mujbegović, Alisa Kubura, Mensura Burina, Nenad Lalović, Nikolina Dukić, Jelena Vladičić Mašić, Mirjana Ćuk, Rajna Stanušić
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 2 (2021)
The HERe2Cure project, which involved a group of breast cancer experts, members of multidisciplinary tumor boards from healthcare institutions in Bosnia and Herzegovina, was initiated with the aim of defining an optimal approach to the diagnosis and
Externí odkaz:
https://doaj.org/article/4233acf6fd3e404d8077ba8f24c2e083
Publikováno v:
Biomedicinska istraživanja, Vol 11, Iss 1, Pp 78-85 (2020)
There is a daily increase in the number of patients with malignant diseases, but with the advances in modern oncology research, the number of survivors treated with malignant diseases is becoming larger and larger. The survival rate after completing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c8d06b10abce2bb94e16ca50ae239215
http://biomedicinskaistrazivanja.mef.ues.rs.ba/wp-content/uploads/2020/08/09-Popovic.pdf
http://biomedicinskaistrazivanja.mef.ues.rs.ba/wp-content/uploads/2020/08/09-Popovic.pdf
Publikováno v:
Биомедицинска истраживања. 11:78-85
There is a daily increase in the number of patients with malignant diseases, but with the advances in modern oncology research, the number of survivors treated with malignant diseases is becoming larger and larger. The survival rate after completing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3168ef298424a387c442ddbf2a5d41a5
https://doi.org/10.5937/bii2001078p
https://doi.org/10.5937/bii2001078p
Autor:
Nikolina Dukić, Sladjana Popovic, Nenad Lalovic, Srdjan Masic, Zdenka Gojkovic, Jelena Vladičić-Mašić
Publikováno v:
Archive of Oncology. 26:10-15
Background: Of all breast cancers 20-25% are HER2 positive. Overexpression of HER2 protein on the surface of the malignant cell leads to excessive cell proliferation through different signaling pathways. Trastuzumab is a human monoclonal antibody tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9816bb99d305e3e164cf27b06dfd518
https://doi.org/10.2298/aoo181112006d
https://doi.org/10.2298/aoo181112006d
Autor:
Nikolina Dukić, Zdenka Gojković, Nenad Lalović, Jelena Vladičić-Mašić, Dragana Jokanović, Srdjan Mašić, Sladjana Popović, Olivera Čančar
Publikováno v:
Biomedicinska istraživanja, Vol 10, Iss 1, Pp 83-90 (2019)
The human epidermal growth receptor 2 (HER2, c-erb-B2) is present in 15-20% of breast cancer at the time of diagnosis. Overexpression of HER2 receptor is associated with more aggressive form of breast cancer. Trastuzumab is a human monoclonal antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0131d0c4c3f802bb1fe67b039ae7e85
http://www.biomedicinskaistrazivanja.com/wp-content/uploads/2019/06/10a-Dukic.pdf
http://www.biomedicinskaistrazivanja.com/wp-content/uploads/2019/06/10a-Dukic.pdf
Autor:
Vladimir Petrovic, Jelena Vladičić Mašić, Vera Todorović, Snežana Zečević, Srđan Mašić, Marko Jović, Nikolina Dukić, Ivan Nikolic
Publikováno v:
Biomedicinska istraživanja, Vol 10, Iss 2, Pp 111-117 (2019)
Introduction. Hematopoiesis is the process of developing blood cells and the formed elements of blood. This dynamic process occurs postnatally in the bone marrow, while the prenatal hematopoiesis is scattered over multiple localizations. It begins in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce77514b81e95269d525efacd8ed93b
https://doi.org/10.7251/bii1902111v
https://doi.org/10.7251/bii1902111v